Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor Cardiovasc Diabetol. 2020;19:160 Lee HF,et al.
Direct Oral Anticoagulants in Atrial Fibrillation Patients with Concomitant Hyperthyroidism. J Clin Endocrinol Metab. 2020. Lee HF
Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia: A Nationwide Cohort Study. Can J Cardiol. 2020 Lee HF,et al.
Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Atrial Fibrillation Patients with Concomitant Peripheral Artery Disease Eur Heart J Cardiovasc Pharmacother. 2019. Lee HF,et al.
Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation Chest. 2019 May 16. pii: S0012-3692(19)31056-6. doi: 10.1016/j.chest.2019.04.108 Chan YH, Lee HF(co-first author),et al.
Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation.J Am Heart Assoc 2019 Mar 5;8(5):e011112. doi: 10.1161/JAHA.118.011112 Lee HF,et al.
End Stage Renal Disease Patients Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers May Reduce the Risk of Mortality: A Taiwanese Nationwide Cohort Study Intern Med J. 2018 May 29. doi: 10.1111/imj.13971. Lee HF, et al.
The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation. Int J Cardiol. 2018 Jun 15;261:78-83. doi: 10.1016/j.ijcard.2018.03.063. Lee HF, et al.
Response to Letter to the Editor J Formos Med Assoc. 2018 May;117(5):456. doi: 10.1016/j.jfma.2017.12.003. Epub 2018 Feb 13.
Lee HF, et al
Crusade Microcatheter-Facilitated Reverse Wire Technique for Revascularization of Bifurcation Lesions of Coronary Arteries. Acta Cardiol Sin. 2018 Jan;34(1):31-36 Lee HF, et al.
Low bone mineral density may be associated with long-term risk of cancer in the middle-aged population: A retrospective observational study from a single center. J Formos Med Assoc. 2018 Apr;117(4):339-345. doi: 10.1016/j.jfma.2017.04.021 Lee HF, et al
Impact of Chronic Kidney Disease on Long -term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention. Korean Circ J. 2017 Jan;47(1):50-55. doi: 10.4070/kcj.2016.0093.
Peng JR, Chang CJ, Wang CL, Tung YC, Lee HF(通訊作者)..
Using Rivaroxaban as Thrombolytic Treatment for a Patient of Pedal Arch Arterial Thrombosis with Suboptimal Result of Endovascular Therapy. Acta Cardiol Sin. 2016 Sep;32(5):623-626. Lee HF*, et al.
Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study. PLoS One. 2016 Jan 5;11(1):e0146343. doi: 10.1371/journal.pone.0146343.
Lee HF, et al.
Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure. Int J Cardiovasc Imaging. 2014 Oct;30(7):1289-95. doi: 10.1007/s10554-014-0468-y.
Lee HF, et al.
Prognostic value of global left ventricular strain for conservatively treated patients with symptomatic aortic stenosis. J Cardiol. 2013;62:301-6. Lee HF, et al.
Association of blood group A with coronary artery disease in young adults in Taiwan. Intern Med. 2012;51:1815-20 Lee HF,et al.